Filing Details

Accession Number:
0000950170-23-071200
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-18 17:56:31
Reporting Period:
2023-12-15
Accepted Time:
2023-12-18 17:56:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420565 Aileron Therapeutics Inc ALRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1790933 Brian James Windsor C/O Aileron Therapeutics, Inc.
738 Main Street #398
Waltham MA 02451
President And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-15 225 $3.37 225 No 4 P Indirect By son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By son
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,122 Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose